1072947-68-2

Upstream product

• 258273-31-3 3-cyano-4-isopropoxybenzoic acid 
• 939999-58-3 (Z)-N'-hydroxy-1H-indazole-5-carboximidamide 
• 1072948-37-8 3-cyano-4-[(1-methylethyl)oxy]benzoyl chloride 
• 15126-06-4 methyl 3-iodo-4-hydroxybenzoate 
• 1261173-10-7 1-methylethyl 3-cyano-4-[(1-methylethyl)oxy]benzoate 
• 213598-11-9 methyl 3-cyano-4-[(1-methylethyl)oxy]benzoate 
• 213598-10-8 methyl 3-bromo-4-isopropoxybenzoate 
• 171050-06-9 3-cyano-4-fluorobenzoic acid 
• 676602-31-6 3-cyano-4-fluorobenzoic acid methyl ester 
• 939999-58-3 N'-hydroxy-1H-indazole-5-carboximidamide 
• 29415-97-2 methyl 3-bromo-4-hydroxybenzoate 
• 14348-41-5 3-bromo-4-hydroxy-benzoic acid 
• 156001-68-2 methyl 3-cyano-4-hydroxybenzoate 
• 99-76-3 methyl 4-hydroxylbenzoate 

Downstream Products

• 1072947-70-6 ethyl 4-[5-(5-{3-cyano-4-[(1-methylethyl)oxy]phenyl}-1,2,4-oxadiazol-3-yl)-2H-indazol-2-yl]butanoate 
• 1072947-69-3 ethyl 4-[5-(5-{3-cyano-4-[(1-methylethyl)oxy]phenyl}-1,2,4-oxadiazol-3-yl)-1H-indazol-1-yl]butanoate 
• 1072948-38-9 ethyl 3-[5-(5-{3-cyano-4-[(1-methylethyl)oxy]phenyl}-1,2,4-oxadiazol-3-yl)-1H-indazol-1-yl]-2,2-dimethylpropanoate 

Relevant academic research and scientific papers

OXADIAZOLE SUBSTITUTED INDAZOLE DERIVATIVES FOR USE AS SPHINGOSINE 1-PHOSPHATE 1 (S1P1) RECEPTOR AGONISTS

Oxadiazole substituted indazole derivatives of formula (I) or pharmaceutical salts thereof having pharmacological activity, processes for their preparation, pharmaceutical compositions containing them and their uses in the treatment of various disorders mediated by S1P1 receptors are disclosed.

OXADIAZOLE SUBSTITUTED INDAZOLE DERIVATIVES FOR USE AS SPHINGOSINE 1-PHOSPHATE 1 (S1P1) RECEPTOR AGONISTS

Oxadiazole substituted indazole derivatives of formula (I) or pharmaceutical salts thereof having pharmacological activity, processes for their preparation, pharmaceutical compositions containing them and their uses in the treatment of various disorders mediated by S1P1 receptor are disclosed.

OXADIAZOLE SUBSTITUTED INDAZOLE DERIVATIVES FOR USE AS SPHINGOSINE 1-PHOSPHATE (S1P) AGONISTS

The present invention provides compounds of formula (I) or salts thereof, having pharmacological activity, processes for their preparation, pharmaceutical compositions containing them and their use in the treatment of various disorders mediated by S1P1 receptors.